Abstract:Background: Gliomas, known for their complex and aggressive characteristics, are deeply influenced by the tumor microenvironment. Matrix metalloproteinases (MMPs) play a vital role in shaping this environment, presenting an opportunity for novel treatment strategies. Methods: We collected six bulk RNA datasets, one single-cell RNA sequencing (scRNA-seq) dataset, and gene sets related to Matrix Metalloproteinases (MMPs), Endothelial-Mesenchymal Transformation (EndMT), and sprouting angiogenesis. We computed enrichment scores using Gene Set Variation Analysis (GSVA) and Single-sample Gene Set Enrichment Analysis (ssGSEA). To analyze immune infiltration, we employed the CIBERSORT method. Data analysis techniques included the log-rank test, Cox regression, Kruskal-Wallis test, and Pearson correlation. For single-cell data, we utilized tools such as Seurat and CellChat for dimensionality reduction, clustering, and cell communication analysis. Results: 1. MMP14 was identified as an independent prognostic marker, highly expressed in myeloid cells in recurrent glioblastoma, highlighting these cells as functionally significant. 2. C-C Motif Chemokine Ligand (CCL) signaling from MMP14+ myeloid cells was identified as a critical immune regulatory pathway, with high C-C Motif Chemokine Receptor 1 (CCR1) expression correlating with increased M2 macrophage infiltration and PD-L1 expression. 3. Patients with high MMP14 expression showed better responses to bevacizumab combined chemotherapy. 4. Signaling pathways involving Visfatin, VEGF, and TGFb, emanating from myeloid cells, significantly impact endothelial cells. These pathways facilitate EndMT and angiogenesis in gliomas. 5. Nicotinamide Phosphoribosyltransferase (NAMPT) showed a strong link with angiogenesis and EndMT, and its association with chemotherapy resistance and differential sensitivity to bevacizumab was evident. Conclusions: MMP14+ myeloid cells are critical in promoting tumor angiogenesis via EndMT and in mediating immunosuppression through CCL signaling in glioblastoma. MMP14 and NAMPT serve as vital clinical indicators for selecting treatment regimens in recurrent glioma. The study suggests that a combined blockade of CCR1 and CD274 could be a promising therapeutic strategy.

Increased Expression of Matrix Metalloproteinase-13 in Glioma is Associated with Poor Overall Survival of Patients

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

[Expression of Notch1, MMP-2 and MMP-9 and Their Significance in Glioma Patients].

MMP-2 Expression and Correlation with Pathology and MRI of Glioma

The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades

The Clinical Significance of MMP-2,VEGF and P16 Expression in Human Glioma

Increased Expression of MMP-2 and MMP-9 Indicates Poor Prognosis in Glioma Recurrence.

Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.

Bioinformatics analysis of MMP14+ myeloid cells affecting endothelial-mesenchymal transformation and immune microenvironment in glioma

Relationship between the expression of matrix metalloproteinase-9 and angiogenesis in glioma and its clinical significance

Expressions of MMP2, TIMP2, Ki-67 and P53 in glioma tissues and their significance

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas

Levels of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9 Proteins in Patients with Glioma.

Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer.

Analysis of the expression and prognostic value of MT1-MMP, β1-integrin and YAP1 in glioma

Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer

Clinical Significance of MMP-2、MMP-9 Expression in Gastrointestinal Stromal Tumor

Expression and Significance of Membrane Type-1 Matrix Metalloproteinase and Matrix Metalloproteinase-2 in Human Glioma

Matrix Metalloproteinase-12 is Associated with Overall Survival in Chinese Patients with Gastric Cancer

Relationship between the Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Brain Tumors

The Relationship Between the Expression of Tumor Matrix-Metalloproteinase and the Characteristics of Magnetic Resonance Imaging of Human Gliomas